LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | PHA-665752 | 3.33 | uM | LJP5 | 1 | F14 | 72 | hr | 2543 | 5746 | 5734 | 1.0020 | 1.0034 |
| SK-BR-3 | PHA-665752 | 3.33 | uM | LJP5 | 2 | F14 | 72 | hr | 2543 | 5716 | 5761 | 0.9921 | 0.9866 |
| SK-BR-3 | PHA-665752 | 3.33 | uM | LJP5 | 3 | F14 | 72 | hr | 2543 | 5810 | 5760 | 1.0085 | 1.0145 |
| SK-BR-3 | PHA-665752 | 10 | uM | LJP5 | 1 | F13 | 72 | hr | 2543 | 4580 | 5734 | 0.7987 | 0.6512 |
| SK-BR-3 | PHA-665752 | 10 | uM | LJP5 | 2 | F13 | 72 | hr | 2543 | 4262 | 5761 | 0.7398 | 0.5490 |
| SK-BR-3 | PHA-665752 | 10 | uM | LJP5 | 3 | F13 | 72 | hr | 2543 | 4289 | 5760 | 0.7445 | 0.5574 |
| SK-BR-3 | PI103 | 0.04 | uM | LJP6 | 1 | I18 | 72 | hr | 2543 | 5067 | 5258 | 0.9635 | 0.9303 |
| SK-BR-3 | PI103 | 0.04 | uM | LJP6 | 2 | I18 | 72 | hr | 2543 | 5060 | 5438 | 0.9305 | 0.8728 |
| SK-BR-3 | PI103 | 0.04 | uM | LJP6 | 3 | I18 | 72 | hr | 2543 | 5333 | 5557 | 0.9596 | 0.9282 |
| SK-BR-3 | PI103 | 0.12 | uM | LJP6 | 1 | I17 | 72 | hr | 2543 | 4284 | 5258 | 0.8146 | 0.6446 |
| SK-BR-3 | PI103 | 0.12 | uM | LJP6 | 2 | I17 | 72 | hr | 2543 | 4315 | 5438 | 0.7935 | 0.6195 |
| SK-BR-3 | PI103 | 0.12 | uM | LJP6 | 3 | I17 | 72 | hr | 2543 | 4844 | 5557 | 0.8716 | 0.7706 |
| SK-BR-3 | PI103 | 0.37 | uM | LJP6 | 1 | I16 | 72 | hr | 2543 | 2830 | 5258 | 0.5381 | 0.1072 |
| SK-BR-3 | PI103 | 0.37 | uM | LJP6 | 2 | I16 | 72 | hr | 2543 | 3339 | 5438 | 0.6140 | 0.2818 |
| SK-BR-3 | PI103 | 0.37 | uM | LJP6 | 3 | I16 | 72 | hr | 2543 | 3702 | 5557 | 0.6661 | 0.3950 |
| SK-BR-3 | PI103 | 1.11 | uM | LJP6 | 1 | I15 | 72 | hr | 2543 | 1899 | 5258 | 0.3611 | -0.2433 |
| SK-BR-3 | PI103 | 1.11 | uM | LJP6 | 2 | I15 | 72 | hr | 2543 | 2041 | 5438 | 0.3753 | -0.1819 |
| SK-BR-3 | PI103 | 1.11 | uM | LJP6 | 3 | I15 | 72 | hr | 2543 | 2233 | 5557 | 0.4018 | -0.1090 |
| SK-BR-3 | PI103 | 3.33 | uM | LJP6 | 1 | I14 | 72 | hr | 2543 | 1560 | 5258 | 0.2966 | -0.3728 |
| SK-BR-3 | PI103 | 3.33 | uM | LJP6 | 2 | I14 | 72 | hr | 2543 | 1752 | 5438 | 0.3222 | -0.2882 |
| SK-BR-3 | PI103 | 3.33 | uM | LJP6 | 3 | I14 | 72 | hr | 2543 | 1771 | 5557 | 0.3187 | -0.2746 |
| SK-BR-3 | PI103 | 10 | uM | LJP6 | 1 | I13 | 72 | hr | 2543 | 1455 | 5258 | 0.2767 | -0.4131 |
| SK-BR-3 | PI103 | 10 | uM | LJP6 | 2 | I13 | 72 | hr | 2543 | 1678 | 5438 | 0.3086 | -0.3157 |
| SK-BR-3 | PI103 | 10 | uM | LJP6 | 3 | I13 | 72 | hr | 2543 | 1740 | 5557 | 0.3131 | -0.2859 |
| SK-BR-3 | Dovitinib | 0.04 | uM | LJP5 | 1 | E24 | 72 | hr | 2543 | 4503 | 5734 | 0.7853 | 0.6275 |